📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies. (2024)

First Author: King LDW

Attributed to: Tropical Infectious Disease Consortium: Expanding and Accelerating Product Development funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.xcrm.2024.101654

PubMed Identifier: 39019011

Publication URI: http://europepmc.org/abstract/MED/39019011

Type: Journal Article/Review

Volume: 5

Parent Publication: Cell reports. Medicine

Issue: 7

ISSN: 2666-3791